Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Survey reveals high engagement with animal medicines advisors
AMTRA is appointed by the Secretary of State of keep its register of Registered Animal Medicines Advisors, or RAMAs
Results provide a snapshot of the perceived performance of AMTRA RAMAs.

A new, independent survey commissioned by regulatory body AMTRA on the understanding of Registered Animal Medicines Advisors (RAMAs) has revealed a high level of engagement and understanding among industry professionals and the farming community. 

AMTRA (Animal Medicines Training Regulatory Authority) is a not-for-profit organisation appointed by the Secretary of State to keep its register of RAMAs (Registered Animal Medicines Advisors), also known as SQPs. Responsible for some 7,000 RAMAs, AMTRA's obligations include an effective disciplinary process to take action in the case of anyone not following the SQP Code of Practice, together with a mandatory system of CPD. 

Respondents to the anonymous telephone survey included professional industry bodies, animal health charities, medicines manufacturers, farmers and influencers within the farming community. Of these, 100 per cent said they recognised the importance of AMTRA RAMAs in providing advice to farmers, while 72 per cent said they were aware of the available training and support.

Respondents to the survey were asked a series of 12 questions and were invited to comment on both their personal and professional engagement with AMTRA and RAMAs. The results show a clear understanding of the importance of AMTRA RAMAs in medicines distribution, including wormers and vaccines, and providing advice on resistance. 

“Principally, the aim of this survey was for us to get a snapshot and evaluate the perceived performance of both AMTRA and our RAMAs within our industry, importantly including the views of farmers,” explained Stephen Dawson, AMTRA secretary-general.

“We are delighted with the overwhelmingly positive feedback we have received, but this exercise has also been important in identifying areas which can be improved, or indeed where messages need to be amplified to create and raise awareness.”

He added: “While there is a good understanding of the training and CPD undertaken by RAMAs, we see the opportunities to work with industry partners, for example, to raise awareness amongst the wider farming community, about their important role in the distribution of animal medicines.

“The challenge is to achieve greater awareness amongst industry, to ultimately encourage greater farmer adoption of this valuable RAMA resource.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.